Mydekla 60mg Tablet
Prescription Required
Marketed By
mylan pharmaceuticals pvt ltd
Pack of
28 Tablet in Bottle
Salt Composition
daclatasvir dihydrochloride(60)
Storage
Keep in cold place
₹1185.88₹5255
77.43% Off
Inclusive of all taxes
1
Mydekla 60mg Tablet
Delivering To: —
All Substitutes
Overview
Mydekla 60mg tablet is a prescription-based antiviral medicine. This tablet is used with other medications in the treatment of chronic (long-lasting) Hepatitis C Virus infection in adults. The active ingredient of the Mydekla tablet is Daclatasvir. Daclatasvir is a direct-acting antiviral (DAA) agent that works against Hepatitis C Virus(HCV) and is used for the treatment of chronic HCV genotype 1 and 3 infections.
Indication
Hepatitis C
Side Effects
Mydekla 60mg tablet may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:
Fatigue
Headache
Nausea
Insomnia (difficulty in sleeping)
Anemia
Diarrhea
Skin rash
Dizziness
Drowsiness
Unusual tiredness
Vomiting
Contact your doctor immediately if you experience any severe or unusual side effects.
How To Use
The doctor determines the dosage of Mydekla 60mg tablet as per the patient's health and other medical conditions. Take this medicine at the same time every day as prescribed by your doctor for effective results. It can be taken orally, with or without food. In case of an overdose, contact your doctor immediately.
Safety Advice
Alcohol
unsafe
It is advisable not to consume alcohol while taking this medicine.
Pregnancy
consult your doctor
Do not take Mydekla 60mg tablets without consulting your doctor if you are pregnant.
Breast Feeding
consult your doctor
Do not take this medicine while breastfeeding without consulting a doctor.
Driving
danger
It is recommended not to drive or operate heavy machinery, as this medicine may cause side effects that impair your ability to do so.
Kidney
caution
Consult your doctor before taking Mydekla 60mg tablets if you have any kidney problems.
Liver
caution
Inform your doctor about your medical history regarding liver disease before starting treatment with Mydekla 60mg
Missed Doses
If you miss a dose, make sure to take it as soon as you remember. Skip the missed dose in case it is already the time for your next scheduled dose. Do not double the dose to catch up.
Quick Tips
FAQs
Mydekla 60mg tablet is an antiviral medicine. This tablet is used with other medications to treat chronic Hepatitis C virus infection in adults.
Store at room temperature (10-30°C). Keep it out of children’s reach. Keep it away from heat, light, and moisture.
If you feel unwell after taking the Mydekla tablet, avoid driving and operating heavy machines.
In kidney disease, Mydekla 60 mg tablet should be administered with caution.
Take it exactly as your healthcare provider tells you. Do not break, crush, or chew the tablet.
Trusted Medicines, Delivered Worldwide
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
Reference
1. Bunchorntavakul, C., & Reddy, K. R. (2015). The efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection. Alimentary pharmacology & therapeutics, 42(3), 258-272.
2. Montgomery, M., Ho, N., Chung, E., & Marzella, N. (2016). Daclatasvir (Daklinza): a treatment option for chronic hepatitis C infection. Pharmacy and Therapeutics, 41(12), 751.
3. Gandhi, Y., Eley, T., Fura, A., Li, W., Bertz, R. J., & Garimella, T. (2018). Daclatasvir: a review of preclinical and clinical pharmacokinetics. Clinical pharmacokinetics, 57(8), 911-928.
4. Yang, S. S., & Kao, J. H. (2016). Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection. Hepatology international, 10(2), 258-266.
5. Keating, G. M. (2016). Daclatasvir: a review in chronic hepatitis C. Drugs, 76(14), 1381-1391.
Related Products
MARKETER DETAILS
mylan pharmaceuticals pvt ltd
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.